Azilsartan Medoxomil is an angiotensin II receptor antagonist and prodrug utilized in the management of hypertension by inhibiting the renin-angiotensin system. This compound, which converts to its active… Read more
![Chemical structure of (5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2'-(5-(2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazol-7-yl)-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1417576-04-5-5-Methyl-2-oxo-13-dioxol-4-ylmethyl-2-ethoxy-1-2-5-2-ethoxy-1-2-5-oxo-45-dihydro-124-oxadiazol-3-yl-11-biphenyl-4-ylmethyl-1H-benzodimida.png&w=3840&q=75)
![Chemical structure of 1-((2'-(1H-Diazirin-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic Acid](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1225044-11-0-1-2-1H-Diazirin-3-yl-11-biphenyl-4-ylmethyl-2-ethoxy-1H-benzodimidazole-7-carboxylic-Acid.png&w=3840&q=75)
![Chemical structure of 1-(1-((2'-(1H-Diazirin-3-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazol-7-yl)ethan-1-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F1-1-2-1H-Diazirin-3-yl-11-biphenyl-4-ylmethyl-2-ethoxy-1H-benzodimidazol-7-ylethan-1-one.png&w=3840&q=75)


Azilsartan Medoxomil is an angiotensin II receptor antagonist and prodrug utilized in the management of hypertension by inhibiting the renin-angiotensin system. This compound, which converts to its active form to effectively lower blood pressure, requires rigorous analytical oversight during pharmaceutical manufacturing and development. This category provides access to essential reference standards, including the active pharmaceutical ingredient, known process and degradant impurities such as 2-ethoxy-1H-benzimidazole-7-carboxylic acid, and related oxadiazole derivatives. These compounds, alongside stable isotope-labelled standards, are critical tools for laboratory professionals performing impurity profiling, method validation, and routine quality control. By utilizing high-quality reference materials, researchers can accurately identify and quantify potential impurities, ensuring compliance with regulatory standards and maintaining the safety and efficacy of the final therapeutic product.